Panbela Therapeutics

PBLA51

High Value

$0.36arrow_drop_down2.70%-$0.01

High Value

Penny Stock

PBLA51

$0.36

arrow_drop_down2.70%-$0.01

High Value

Penny Stock

Performance History

Key Stats
Open	$0.33
Prev. Close	$0.37
EPS	121.67
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$1.79M

	LOW	HIGH
Day Range	0.33	0.36
52 Week Range	0.30	38.00

Ratios

Revenue	-



EBITDA Margin %	-

EPS	121.67

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Panbela Therapeutics (PBLA)

Panbela Therapeutics Inc. (PBLA) is a biotechnology company that focuses on the development of innovative therapeutics for the treatment of cancer. The company's main objective is to address the unmet medical needs of cancer patients, particularly those with solid tumors. Panbela Therapeutics is committed to advancing its pipeline of drug candidates, which are designed to target specific molecular pathways involved in cancer growth and progression.

One of Panbela Therapeutics' most promising drug candidates is currently in phase 2 clinical trials. This investigational therapy has shown promising results in preclinical studies, demonstrating its potential to inhibit tumor growth and improve patient outcomes. The company is also exploring the use of combination therapies, leveraging its drug candidates along with other standard-of-care treatments, to enhance their therapeutic effect.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Jennifer K. Simpson C.R.N.P., CRNP, M.S.N., Ph.D.
Headquarters: Waconia
Employees: 6
Exchange: NASDAQ

Keep an eye on Panbela Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Panbela Therapeutics's (PBLA) price per share?

The current price per share for Panbela Therapeutics (PBLA) is $0.36. The stock has seen a price change of -$0.01 recently, indicating a -2.7% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Panbela Therapeutics (PBLA)?

For Panbela Therapeutics (PBLA), the 52-week high is $38, which is 10.46K% from the current price. The 52-week low is $0.3, the current price is 20% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Panbela Therapeutics (PBLA) a growth stock?

Panbela Therapeutics (PBLA) has shown an average price growth of 0.41% over the past three years. It has received a score of -6 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Panbela Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Panbela Therapeutics (PBLA) stock price performance year to date (YTD)?

As of the latest data, Panbela Therapeutics (PBLA) has a year-to-date price change of -97.99%. Over the past month, the stock has experienced a price change of -5.26%. Over the last three months, the change has been -5.76%. Over the past six months, the figure is -67.57%.

help

Is Panbela Therapeutics (PBLA) a profitable company?

Panbela Therapeutics (PBLA) has a net income of -$25.26M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 100%, providing insight into the company's sales performance and growth. Operating income is noted at -$51.29M. Furthermore, the EBITDA is $0.

help

What is the market capitalization of Panbela Therapeutics (PBLA)?

Panbela Therapeutics (PBLA) has a market capitalization of $1.8M. The average daily trading volume is 10.63K, indicating the stock's liquidity and investor engagement.